FUSN — Fusion Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $1.83bn
- $1.67bn
- $2.07m
U.S. STOCKS ON THE MOVE-Stitch Fix, Illumina, U.S. retail stocks, banks
U.S. STOCKS ON THE MOVE-Cogent Biosciences, Roblox, U.S. banks, retail stocks
Fusion Pharmaceuticals rises on radioisotope supply deal with Niowave
Brief: Fusion Pharmaceuticals And Niowave Announce Actinium-225 Collaboration And Supply Agreement
U.S. STOCKS ON THE MOVE-Novavax, Signet Jewelers, Zendesk, Roblox
U.S. STOCKS ON THE MOVE-Tesla, Roblox, Novavax, Couchbase
Fusion Pharma hits record low after delay in cancer drug trials
Brief: Fusion Pharmaceuticals Provides Updates On FPI-1434 And FPI-1966 Clinical Programs
Fusion Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Fusion Pharmaceuticals Q1 Loss Per Share $0.46
Brief: Fusion Pharmaceuticals Announces First Quarter 2022 Financial Results And Clinical Program Updates
Fusion Pharmaceuticals Inc expected to post a loss of 48 cents a share - Earnings Preview
Brief: Fusion Pharmaceuticals Inc - Entered Into A $75 Million Loan And Security Agreement
FDA nod for Novartis's radiotherapy to bode well for other biotechs - Guggenheim
Brief: Fusion Pharmaceuticals Reports Q4 Net Loss Of $0.40 Per Share
Brief: Fusion Pharmaceuticals Q4 Loss Per Share $0.40
Brief: Fusion Pharma To Collaborate With Pepscan To Develop Peptide-Based Radiopharmaceuticals
Brief: Fusion Pharmaceuticals Announces Research Collaboration With 48Hour Discovery To Develop Peptide-Based Radiopharmaceuticals
Brief: Fusion Pharma Nominates First Targeted Alpha Therapy Candidate In Collaboration With Astrazeneca For Ind-Enabling Studies